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Abstract
Background: There is a dearth of validated tools measuring posttraumatic stress disorder (PTSD) in low and middle-
income countries in sub-Saharan Africa. We validated the Shona version of the PTSD Checklist for DSM-5 (PCL-5) in a
primary health care clinic in Harare, Zimbabwe.
Method: Adults aged 18 and above attending the clinic were enrolled over a two-week period in June 2016. After
obtaining written consent, trained research assistants administered the tool to eligible participants. Study participants
were then interviewed independently using the Clinician Administered PTSD Scale (CAPS-5) as the gold standard by
one of five doctors with training in mental health.
Result: A total of 204 participants were assessed. Of these, 91 (44.6%) were HIV positive, 100 (49%) were HIV negative,
while 13 (6.4%) did not know their HIV status. PTSD was diagnosed in 40 (19.6%) participants using the gold standard
procedure. Using the PCL-5 cut-off of ≥33, sensitivity and specificity were 74.5% (95%CI: 60.4–85.7); 70.6% (95%CI:
62.7–77.7), respectively. The area under the ROC curve was 0.78 (95%CI: 0.72–0.83). The Shona version of the PCL-
5 demonstrated good internal consistency (Cronbach’s alpha = 0.92).
Conclusion: The PCL-5 performed well in this population with a high prevalence of HIV. There is need to explore
ways of integrating screening tools for PTSD in interventions delivered by lay health workers in low and middle-
income countries (LMIC).
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Background
In sub-Saharan Africa, people living with HIV (PLWH)
have a high rate of post-traumatic stress disorder
(PTSD) [1, 2]. The negative experience of being HIV
positive is cumulative with PLWH exposed to multiple
HIV-related stressors and losses [3] which can lead to
PTSD symptomatology.
Stressors, both acute and chronic, that people in LMIC
are exposed to often occur on a daily basis. Political and
economic instability, including poverty and disparity
with its consequences of food scarcity and lack of access
to medical care are some of the stressors. Furthermore,
lack of education, interpersonal violence (IPV), and ex-
posure to weather phenomena due to climate change
can contribute to poor mental health outcomes includ-
ing stress related disorders [4].
Women are reported to be at greater risk of developing
symptoms of PTSD [5] with cumulative effects of multiple
traumas being common and associated with worse psychi-
atric and other chronic medical comorbidity [6–8].
In South Africa, PLWH have been found to have high
prevalence of persisting psychiatric disorders with PTSD
rates at follow-up of 20% being associated with a longer
duration of infection and low baseline functionality [9].
The incidence of HIV-related PTSD in a cross-sectional
study in the Western Cape, South Africa, was found to
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be at 40% [10]. Receiving an HIV-diagnosis was experi-
enced as a traumatic index event for 36.4% in a popula-
tion of recently diagnosed persons [9, 11].
The use of different PTSD assessment tools as well as the
diversity with which traumatic events have been defined
have contributed to varying outcomes in studies of PTSD
[12]. Receiving a life-threatening diagnosis meets the
threshold for consideration as a traumatic event for the de-
velopment of PTSD [13] and was included in the Diagnos-
tic and Statistical Manual of Mental Disorders DSM-IV
(4th ed.; DSM-IV; American Psychiatric Association, 1994).
In general, too little is known about the prevalence of
PTSD and PTSD related to HIV infection and its impact
on health outcomes such as, health seeking behavior,
treatment adherence and quality of life in sub-Saharan
Africa. Furthermore, validated tools are scarce. For
Zimbabwe, efforts have been made to validate screening
tools for common mental disorders such as depression
and anxiety for use in primary health care settings but
none have been validated for PTSD [14] therefore this
study seeks to address this deficit. The most appropriate
current screening tool which based on DSM-5 is the
Posttraumatic Stress Disorder Checklist (PCL-5) [15]
which has not been validated in Africa. The Posttrau-
matic Stress Disorder Checklist (PCL) was developed at
the National Center for PTSD [15]. It is a self-report
measure that is widely used in western contexts and has
been found to have very good psychometric properties
in various settings [16–20].
Methods
The validation exercise was carried out as a cross-
sectional study at the largest clinic in the suburb of Mbare
near the central business district of Harare, Zimbabwe.
Adults aged 18 and above attending the clinic were en-
rolled over a two-week period in June 2016. Pregnant
women in their last trimester and women within the
3-month postnatal period were excluded to exempt post-
natal depression [21], as were those who were unable to
understand the purpose of the study.
After having obtained written consent, research assis-
tants trained in the use of tablet computer facilitated
data collection, administered the tool. Study participants
were then clinically assessed by one of five doctors
trained in mental health using the CAPS-5 (Clinician
administered PTSD scale – 5) as the gold standard.
The study was approved by the medical research council
of Zimbabwe (MRCZ, reference MRCZ/A/1732) and by
the Health Research Ethics Committee at Stellenbosch
University (reference S14/05/102).
Sample size
We aimed to recruit a representative sample of n = 150
patients from a primary care clinic. We calculated that a
minimum of 75 participants who scored positive on the
reference standard for PTSD (CAPS-5) and 75 who
scored negative would provide good precision for per-
formance indicators for the PCL-5 achieving a sensitivity
of 74.5% (95%CI:60.4–85.7%); specificity of 70.6%
(95%CI:62.7–77.7%), positive predictive value (PPV) of
45.8% (95%CI:34.8–57.1%) and negative predictive value
(NPV) of 89.3% (95%CI:82.3–94.2%).
Translation of tools
The PCL-5, the LEC-5 (Life Events Checklist - 5) and
the clinician administered PTSD scale for DSM-5
(CAPS-5) were translated from English into the local
language Shona by a bilingual clinical social worker, and
a bilingual psychiatrist (DC).
This draft Shona version was reviewed by a team of
five lay health workers (LHW) working in a primary care
mental health program called the Friendship Bench [22],
five nurses working in the psychiatric ward of Harare
Central Hospital together with a psychologist.
This phase focused on ensuring contextual equivalence
to the original versions based on their understanding
and use of local terms for trauma symptomatology.
An independent language expert back-translated the
Shona version into English. The first author together with
the social worker and the psychiatrist examined both ori-
ginal and back-translated versions and resolved any dis-
crepancies by consensus. Translation and back-translation
were carried out using a standard approach [23].
The PCL-5
The PCL was revised to match the adapted DSM-5 criteria
for PTSD. The PCL-5 features an adapted answer scale
ranging from 0 = not at all to 4 = extremely, thus making
the theoretical lowest score 0. It measures 4 symptom
clusters; the original clusters intrusion, avoidance and
hyper-arousal and the added cluster of negative alterations
in cognition and mood with three items (blame, negative
emotions, and reckless or self-destructive behavior). Item
scores can be summed for an overall severity score as well
as for individual symptom cluster sums. A PTSD diagnosis
can be made provisionally considering items rated 2 =
moderately or higher as according to the DSM-5 diagnos-
tic rule (at least one B, one C, two D, and two E symptoms
present). In an empirical calibration, Blevins et al. (2015)
found the psychometric properties for the PCL-5 for a US
American college convenience sample with subjects who
self-identified as having PTSD as follows: internal
consistency α = 0.94 and test-retest reliability r = 0.82, 95%
CI [0.71, 0.89] [16].
Clinician administered PTSD scale (CAPS-5)
The Clinician-administered PTSD scale CAPS-5 for
DSM-5 [24] was used as the gold standard. It was
Verhey et al. BMC Psychiatry  (2018) 18:109 Page 2 of 8
derived from the CAPS for DSM-IV [25] and adjusted
for the changes of the PTSD diagnosis in DSM-5
(American Psychiatric Association, 2013). The CAPS-5
is a structured clinical interview which allows the clin-
ician to make a diagnosis of PTSD according to the
criteria described in the DSM-5. Furthermore, overall
symptom severity as well as global, social, occupational
and personal impairment are assessed. The main Criter-
ion (A), the traumatic event, is assessed with the added
Life Events Checklist for the DSM-5 (LEC-5) [26].
The life events checklist for DSM-5 (LEC-5)
The LEC-5 is a self-report questionnaire asking for the
prevalence of 16 potentially traumatic life-time events
plus an added open category (“any other very stressful
event or experience”) with five answer categories [26].
We used the LEC-5 in combination with the PCL-5.
SSQ-14
The Shona Symptom Questionnaire (SSQ-14) [27] was
developed and recently re-validated in Zimbabwe in a
HIV-population [14]. Most of the items are common to
those found in tools for depression worldwide such as
sleep disturbance and suicidal thoughts; others are local
idioms of emotional distress including ‘thinking too
much’. Participants are asked if they have experienced a
list of common mental health symptoms in the past
week. Each of the 14 items is scored dichotomously as
yes (1) or no (0). With the optimal cut-off of ≥9, the sen-
sitivity and specificity for the SSQ-14 against a diagnosis
of depression and/or general anxiety were 84% (95% CI:
78–89) and 73% (95%CI:63–81), respectively. Internal
reliability was high (Cronbach α=0.74) [14].
Training procedure
Study personnel (four research assistants, six LHWs and
five medical doctors) working in the psychiatric unit of
Harare Central hospital attended a two-week training
using a guide initially developed by the authors (RV and
DC). The research assistants were trained in data collec-
tion methods using the socio-demographic forms and
the screening tools. The medical doctors were trained in
the use of the CAPS-5 through a discussion forum led
by RV which involved going through the diagnostic
criteria, building consensus on how to manage clinically
severe cases during the validation, and procedures for
ensuring fidelity. RV and DC observed the doctors dur-
ing role-play using the tool.
All raters were involved in a pilot study with patients
visiting the psychiatric outpatient unit. Cohen’s Kappa
was found to be high (k = 0.91) using a random sample
size of n = 26. Participants in the pilot study were differ-
ent from the participants of the validation exercise. The
referral pathways for participants meeting criteria for
PTSD and other acute medical conditions were deter-
mined as that they should be seen by the medical officer
first, for assessment, before being referred to a tertiary
psychiatric facility if needed.
Data collection
Stage 1: Every morning during the study period, an
appointed research assistant obtained the register of all
adult patients waiting to be seen. The research assistant
randomly selected clinic attendees based on a computer-
generated random number sequence. Fifteen randomly
selected participants were invited at one time to a quiet
and private space where eligibility was determined. In-
formed written consent was sought from all those eli-
gible. The four research assistants administered the SSQ
and the PCL-5 to participants in randomly assigned
alternating questionnaire order and also collected socio-
demographic information such as age, gender, HIV sta-
tus, marital and employment status. The interviews took
20–30 min and were conducted in a quiet space desig-
nated for the study team. Although the PCL-5 including
the LEC and the SSQ are self-report tools, we chose to
have them administered by trained research assistants as
it was found in prior validation exercises using the same
approach that tablet computer-use was not familiar to
most of the clinic attendees [21].
Stage 2: Following administration of the screening
tools, participants were referred to one of five medical
doctors who conducted the CAPS-5. The doctors were
blinded to the screening data. Each doctor asked the
participant to recall the index event that was chosen, or
the worst event if several were indicated, from the LEC-
5 for the subsequent clinical interview. The CAPS-5
interview lasted 30–60 min in a private and quiet room.
In case of a participant not reporting any event, the
interview was not carried out.
All those needing acute psychiatric care were fur-
ther assessed for treatment and referral to the psychi-
atric hospital.
Data management
All data was double entered onto a password-protected
database using Stata (version 13). No participant identifi-
able information was entered into the database. Ethical
considerations and confidentiality for all participants
were respected in accordance with Medical Research
Council of Zimbabwe guidelines.
Analysis
The performance of the PCL-5 was measured against
the CAPS-5 as the gold standard. We estimated the sen-
sitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) for different cut-points.
The optimal cut-point was chosen to deliver a good
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balance between sensitivity and specificity. Results were
presented in the form of a ROC curve which plots the
true positive rate (sensitivity) against the false positive
rate (specificity) [28]. The area under a ROC curve
(AUC) quantifies the overall ability of the test to dis-
criminate between those individuals with the outcome
and those without the outcome.
Internal reliability was estimated using Cronbachs’ α.
All analyses were conducted using Stata (version 13).
Results
Sample description
A total of the 204 (74.1%) participants were recruited
during a 2-week period from a total of 275 who had
been invited to take part. Seventy one were not illegible
or declined participation. Of the final participants, 163
(85.3%) were female, 133 (69.6%) were married, and 139
(59%) had completed secondary education (Table 1).
Overall sample mean age was 34 years. There were 108
(65.5%) participants who were unemployed. HIV sero-
status was known for 191 (93.6%) participants, of whom
91 were HIV positive (44.6%). 13 (6.4%) did not know or
refused to reveal their HIV status. Out of the 91 partici-
pants who were HIV positive, 79.1% were female. Being
aged 40 and above (OR 15.03 CI6.35–35.57), being
widowed (OR CI8.41 2.75–25.70) and having a SSQ 9
and above (OR 2.15 CI1.19–3.87) were associated with
HIV positive status, respectively (Table 1).
Forty-two (46.2%) of the HIV positive participants
(n = 91) scored equal or above the cut-off score for PTSD.
On the measure of depression (SSQ-14), 45 (49.5%) of this
group scored above cut-off.
Amongst all 191 participants for whom the HIV status
was known, 76 (39.7%) scored equal or above cut-off for
PTSD as measured by the PCL-5.
Traumatic events reported using LEC-5
On the self-experienced answer category, participants
(n = 204) were asked to indicate all the events that
happened to them in their entire life. The following five
index events were reported as most common: physical
assault [reported by 132 participants (64.7%)], the open
category any other very stressful event or experience
[130 participants (63.7%)], sudden, unexpected death of
someone who was close to the participant (113 partici-
pants, 55.4%), life-threatening illness or injury (89 partic-
ipants, 43.6%), as well as severe human suffering (86
participants, 42.2%).
Traumatic events reported in the CAPS-5
In the clinical interview participants reported a similar
distribution of events as the LEC-5. A total of 40 (19.6%)
cases of PTSD were identified using our gold standard
procedure. Qualifying traumatic events reported were
categorized as follows: victim of physical, often com-
bined with sexual assault (18 cases, 45%), being diag-
nosed with HIV as a life-threatening illness in 13 cases
(32.5%) and having experienced sudden death of a per-
son close to the participant in 9 cases (22.5%).
Performance of the PCL-5 against the CAPS-5
A cut-off of ≥33 provided the highest proportion of partic-
ipants correctly diagnosed compared with the CAPS-5 in-
strument. With this cut-off, sensitivity was 74.5% (95% CI:
60.4–85.7) and specificity was 70.6% (95% CI: 62.7–77.7)
(Table 2).
The PPV was 45.8% (95% CI: 34.8–57.1) and the NPV
89.3% (95% CI: 82.3–94.2) with Cronbach’s α = 0.92.
After stratification by HIV status the sensitivity for
PLWH was 78.6% (59.0–91.7), and the specificity was
68.3% (55.3–79.4). The PPV was 52.4% (36.4–68.0), the
NPV 87.8% (75.2–95.4) using the cut of ≥33.
The ROC curve for the performance of the PCL-5
gave an AUC of 0.78 (95% CI: 0.72–0.83) (Fig. 1).
Discussion
The primary goal of this study was to validate the PCL-5
as the most current, DSM-5 keyed, PTSD measure (5th
ed.; DSM-5; American Psychiatric Association, 2013)
and to determine its utility and applicability in our con-
text. We have validated other relevant tools for our work
in CMD [14] but none for PTSD specifically.
The PCL-5 has not been validated within a comparable
setting before, focusing on a population with high HIV
prevalence.
The optimum cut-off score was found to be ≥33, a
value which gave us a sensitivity of 74.5% (95%CI
60.4–85.7) and a specificity of 70.6% (95%CI 62.7–77.7).
There was a difference after stratification according to
HIV status [sensitivity = 78.6% (95%CI 59.0–91.7) and
specificity = 68.3% (95%CI 55.3–79.4)]. This suggests the
tool is more sensitive and less specific for PLWH com-
pared to the results for the whole sample. This is further
supported by the positive and negative predictive values
which were 45.8% (34.0–57.1) and 89.3% (82.3–94.2)
respectively for all participants (n = 204). The ROC
curve (Fig. 1) gave an area under the curve (AUC) of 0.78
(95% CI0.716–0.834). The sensitivity of the tool being
higher amongst PLWH was also the case in our earlier
validation of tools for CMD [14]. There was good internal
consistency (Cronbach’s α = 0.92).
Our results show that it is feasible to validate PTSD
tools in a low resource setting using locally trained re-
searchers. Although the PCL-5 is originally developed in
a high-income setting where the context is different, we
have shown that using cross-cultural methods as in earl-
ier validation studies [21] is possible for PTSD tool val-
idation. The inclusion of LHWs who are the delivering
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agent of the Friendship Bench intervention also makes
the eventual use of the PCL-5 tool in their work at pri-
mary care level further possible. Including staff at all
levels of the health system is important when developing
interventions as this contributes to a stronger buy-in
and increases the chances of the tool being used by all
[29]. The results of this validation study will enable local
researchers working on epidemiological and intervention
Table 1 Socio-demographic characteristics of all participants by HIV status (n = 191)b
Characteristic HIV positive (n = 91) HIV negative (n = 100) Logistic regressiona
N % N % OR 95% CI p-value
Gender 0.02
Male 19 20.9 9 9.0 1 –
Female 72 79.1 91 91.0 0.37 (0.16–0.88)
Age group < 0.001
< 30 16 17.6 63 63.0 1 –
30–39 33 36.3 26 26.0 5 (2.36–10.60)
40+ 42 46.2 11 11.0 15.03 (6.35–35.57)
Marital status < 0.001
Married 54 59.3 79 79.0 1 –
Single 14 15.4 17 17.0 1.2 (0.55–2.65)
Widowed 23 25.3 4 4.0 8.41 (2.75–25.70)
Education 0.009
Less than ‘O’ level 45 49.5 31 31.0 1 –
O′ level or more 43 50.6 69 69.0 0.46 (0.25–0.83)
Current employment status 0.11
Unemployed 46 50.5 62 62.0 1 –
Permanent FT or PT 8 8.8 3 3.0 3.59 (0.90–14.30)
Casual/self-employed 37 40.7 35 35.0 1.42 (0.78–2.59)
Main income source < 0.001
Own business/salary 58 65.2 40 40.4 1 –
Partner/family 22 24.7 51 51.5 0.3 (0.16–0.57)
No income 9 10.1 8 8.1 0.78 (0.28–2.18)
Suffer from chronic illness < 0.001
No 10 11.0 66 66.0 1 –
Yes 81 89.0 34 34.0 15.72 (7.23–34.18)
Reason for clinic visit < 0.001
HIV-related 37 40.7 1 1.0 1
Routine/family/antenatal 34 37.4 54 54.0 0.02 (0.00–0.13)
Other reason 20 22.0 45 45.0 0.01 (0.00–0.09)
Negative life events in last 6 months 0.21
No 20 22.0 30 30.0 1 –
Yes 71 78.0 70 70.0 1.52 (0.79–2.93)
SSQ ≥ 9 0.01
No 46 50.6 68 68.7 1
Yes 45 49.5 31 31.3 2.15 (1.19–3.87)
PCL≥ 33 0.09
No 49 53.8 66 66.0 1
Yes 42 46.2 34 34.0 1.66 (0.93–2.98)
aunivariate logistic regression for outcome HIV+
bParticipants who did not know or reveal their HIV status excluded (n = 13)
Verhey et al. BMC Psychiatry  (2018) 18:109 Page 5 of 8
studies with a focus on PTSD to work with a tool vali-
dated using an evidence based approach.
The PTSD prevalence of 46% amongst seropositive
participants highlights the close link between HIV-status
and PTSD prevalence, therefore it may be necessary to
include screening for PTSD in the expanding HIV clinics
in the country. Currently PLWH are screened using the
SSQ-14 [27] which shows some overlap of symptomatol-
ogy with PTSD (Table 1), however, there is need for
PTSD specific screening in view of the high prevalence
of PTSD. The prevalence of PTSD for all participants
(n = 204) according to the gold standard measure
CAPS-5 was 19.6%. Community studies have shown that
trauma exposure is higher, often multiple, and associated
with several chronic physical conditions [30].
A positive HIV sero-status is described as a traumatic
event [31, 32]. In our study, one third (32.5%) of the
PTSD cases identified by the gold standard clinical inter-
view were found to have HIV infection as the qualifying
traumatic event.
Being found out to be HIV positive is often met
with interpersonal violence by partners or family
members [33] with anticipatory fear often leading to
non-testing or non-following up of treatment seeking
behavior [34].
Whereas HIV can arguably be managed effectively
in Western countries, the situation is different for the
developing world. Poverty and unemployment, lack of
access to medication and medical care, unavailability
of adequate food, housing, risk of exposure to ill-
nesses and to being re-infected due to lack of aware-
ness and risky sexual practices as well as exposure to
stigma and stigma-related interpersonal violence all
comprise daily traumatic events for the HIV popula-
tion in Zimbabwe.
The cumulative effect of these stressors is seen in the
high prevalence of CMD of 49.5% amongst seropositive
participants.
The Friendship Bench Program has had a successful,
targeted approach to CMD [35], however we realize that
PTSD identification could contribute towards adequately
addressing the needs of primary care patients.
The use of psychological interventions to address
common mental disorders (CMD) in PLWH in sub-
Saharan Africa, their scaling-up, as well as their moni-
toring and evaluation underscores the importance of
Fig. 1 ROC curve for PCL-5 against CAPS 5 (n = 204)
Table 2 Sensitivity, specificity, PPV & NPV for PCL-5 cut-off ≥33 for whole sample and for PLWH only
Sensitivity (95%CI) Specificity (95%CI) PPV (95%CI) NPV (95%CI)
N = 204 74.5% (60.4–85.7) 70.6% (62.7–77.7) 45.8%(34.8–57.1) 89.3% (82.3–94.2)
N = 91 PLWH only 78.6% (59.0–91.7) 68.3% (55.3–79.4) 52.4% (36.4–68.0) 87.8% (75.2–95.4)
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administering validated tools in rigorously conducted
clinical trials [36, 37].
The PCL-5 has been developed in a western setting, as
have most other psychological tools. Traumatic events
according to the DSM-5 are defined as events that are
linked to actual or threat of death, serious injury, or sexual
violence experienced by self or close others, witnessed as
well as heard of. Given the living situation for the majority
of the population in LMIC, in our view the definition of a
traumatic event has to be broadened. In LMIC, a wider
range of circumstances hold a potential life threat for the
population, as seen in the burden of disease studies [38].
Furthermore, people in LMIC are often exposed to mul-
tiple traumas [39] and have therefore a pronounced need
for adequate, accessible and evidence-based care.
Limitations
The gold standard interviews were carried out by medical
doctors who all had a minimum of 2 years of work experi-
ence in psychiatry but no formal training in psychiatry. They
were trained and supervised in the use of the tool by the first
author together with the second author. The duration of
training was less in comparison to other settings [16].
Study participants were urban dwellers visiting primary
care clinics, therefore generalization beyond primary care
settings is not possible. Furthermore, most of the study par-
ticipants were female (85% females in our sample) which is
common in this setting as shown in previous work [35, 40,
41], therefore, our finding may not be gender-sensitive.
PCL-5 and SSQ were administered in interview format
despite them being designed for self-administration.
Interviews were conducted by trained research assistants
as study participants were not familiar with self-
administration on tablet computers which were used for
the data collection. A limitation of this approach is that
participants might have displayed a social desirability bias
[42] and therefore decreased the validity of the responses.
We did not investigate aspects of trauma attribution,
resilience and vulnerability of individuals in this study nor
did we discuss possible co-morbidities, all these are seen
as associated with the development of PTSD [43, 44].
Conclusion
It is possible to validate screening tools for PTSD in a
low resourced setting with a high HIV prevalence.. We
found the PCl-5 to have a good internal consistency with
Cronbach’s α = 0.92, and with a cut-off score of 33 it
showed good performance. Furthermore, our cut-off
score is in line with what is suggested by the authors of
the PCL-5 in its revised civilian version [16].
There is a need for integrating PTSD screening in
primary care due to the high rate of PTSD within our
study populations (45% for HIV positive and 34.3% for
HIV negative participants, respectively).
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